Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aytu BioScience (AYTU)
:AYTU
Earnings Data
Report Date
May 19, 2025TBA Not Confirmed
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.17Last Year’s EPS
-0.52Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 12, 2025
|% Change Since: -2.88%
|Next Earnings Date:May 19, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted positive trends in prescription growth and cost savings, while also addressing challenges like declining ADHD revenue and gross margins due to manufacturing transitions. The company is optimistic about future growth and cash flow positivity.Company Guidance
During the Aytu BioPharma Fiscal 2025 Q2 earnings call, CEO Josh Disbrow highlighted several key metrics and strategic initiatives that have shaped the company's recent performance and future outlook. The company achieved positive sequential prescription growth for both its ADHD and pediatric portfolios for the first time since late 2022. ADHD portfolio net revenue was reported at $13.8 million for Q2, reflecting a 16% sequential increase on an apples-to-apples basis, excluding a one-time payer resolution adjustment. Pediatric portfolio net revenue saw significant growth, up 86% sequentially, contributing to a $10 million annualized run rate. Aytu BioPharma also announced it had achieved its seventh consecutive quarter of positive adjusted EBITDA and its second consecutive quarter of net income. The company's cash balance at the end of December 2024 was $20.4 million, up from $20.1 million at the end of September 2024. Cost-saving measures, including $2 million in expected future annual savings, have been a focus, alongside leveraging the Aytu RxConnect platform, which has contributed to improved payer coverage and broadened distribution efforts. These efforts come as the company continues to optimize its operations, including pausing pipeline spending and exiting manufacturing operations, while focusing on driving growth in its prescription business.Positive Sequential Prescription Growth
Both ADHD and Pediatric portfolios returned to positive sequential prescription growth for the first time since late 2022.
Cost Optimization
Corporate optimization initiatives are expected to drive efficiencies with at least $2 million in annual future cost savings.
Seventh Consecutive Positive Adjusted EBITDA
The company reported its seventh consecutive quarter of positive adjusted EBITDA and second consecutive quarter of net income.
Pediatric Portfolio Recovery
Pediatric portfolio net revenue was up 86% sequentially, with significant gains in antihistamine prescriptions.
Cash Balance Increase
Cash balance at the end of December was $20.4 million, up slightly from $20.1 million at the end of September.
---
AYTU Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
AYTU Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 12, 2025 | $1.39 | $1.38 | -0.72% |
| Nov 13, 2024 | $1.74 | $1.55 | -10.92% |
| Sep 26, 2024 | $2.85 | $2.36 | -17.19% |
| May 15, 2024 | $3.06 | $2.96 | -3.27% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Aytu BioScience (AYTU) report earnings?
Aytu BioScience (AYTU) is schdueled to report earning on May 19, 2025, TBA Not Confirmed.
What is Aytu BioScience (AYTU) earnings time?
Aytu BioScience (AYTU) earnings time is at May 19, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AYTU EPS forecast?
AYTU EPS forecast for the fiscal quarter 2025 (Q3) is -0.17.
---